Zoya Treyster
Allergy & Immunology · New York, NYNPI 1578852240
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Genentech USA, Inc. at 56.4% of the total. Reporting peaked in 2023 at $6,591 and has fallen 85.9% since, to $927 in 2025.
Across 109 payments — averaging $78.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$5K
- Genentech, Inc.$1K
- GSK$343
- AstraZeneca$299
- Sanofi$277
- Kaleo, Inc.$276
- plus $1K from 22 others
Across 15 payments — averaging $5942.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$89K
What the payments were for
- Consulting fees$4,96058%
- Travel & lodging$98011%
- Food & beverage$2,43528%
- Education$1812%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 11 | $4,830 |
| Genentech, Inc. | 2 | $1,238 |
| GSK | 12 | $343 |
| AstraZeneca | 12 | $299 |
| Sanofi | 11 | $277 |
| Kaleo, Inc. | 13 | $276 |
| Regeneron Healthcare Solutions, Inc. | 8 | $257 |
| Novartis | 8 | $211 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $115 |
| Ascendis Pharma Endocrinology Inc | 3 | $101 |
| Novo Nordisk | 3 | $78 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| Tolmar, Inc. | 2 | $51 |
| Biocryst US Sales Co., LLC | 2 | $45 |
| Pfizer | 2 | $41 |
| Neurocrine Biosciences, Inc. | 1 | $37 |
| Hologic Sales And Service, LLC | 1 | $37 |
| Greer Laboratories, Inc. | 1 | $26 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $25 |
| IBSA Pharma Inc. | 1 | $24 |
| Merck | 1 | $22 |
| Amgen | 1 | $19 |
| Phadia US Inc. | 1 | $18 |
| Shire North American Group Inc | 1 | $17 |
| Grifols USA, LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,556 in reported general payments places this provider in the 75th percentile of 320 allergy & immunology providers in New York.
Other allergy & immunology in New York
- Ujwala KazaNew York$1.1M
- Robert SporterNew York$946K
- Richard InselNew York$269K
- Purvi ParikhNew York$183K
- Arthur LubitzNew York$165K
- Ama AlexisNew York$120K
- Boyan HadjievNew York$97K
- Charlotte Cunningham-RundlesNew York$95K
- Paula BusseNew York$95K
- Hale YarmohammadiNew York$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.